Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.

ABSTRACT:

Background

We estimated trends in total and out-of-pocket (OOP) costs around the first year of diagnosis for privately insured nonelderly adult cancer patients.

Methods

We constructed incident cohorts of breast, colorectal, lung, and prostate cancer patients diagnosed between 2009 and 2016 using claims data from the Health Care Cost Institute. We identified cancer-related surgery, intravenous (IV) systemic therapy, and radiation and calculated associated total and OOP costs (in 2020 US dollars). We assessed trends in health-care utilization and cost by cancer site with logistic regressions and generalized linear models, respectively.

Results

The cohorts included 105 255 breast, 23 571 colorectal, 11 321 lung, and 59 197 prostate cancer patients. For patients diagnosed

SUBMITTER: Shih YT 

PROVIDER: S-EPMC9552304 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature